Examines lipid-lowering effects of anthocyanin nanocarriers in an intestinal model, suggesting enhanced stability and bioactivity.
Blueberry anthocyanins (BAs) exhibit strong antioxidant and lipid-regulating activities; however, their chemical instability and low oral bioavailability limit their practical application. In this study, two plant-based bilayer nanocarriers were developed using soybean lecithin as the lipid core and gum arabic (GA) or carrageenan (CGN) as the shell polysaccharide. The optimized systems achieved encapsulation efficiencies of 79.7% and 81.9%, respectively. Structural analyses showed that anthocyanins were stably incorporated into the carriers through multiple non-covalent interactions and transformed from a crystalline to an amorphous state. The two shell polysaccharides exhibited distinct conformation-dependent protective behaviors: GA provided better thermal protection, whereas CGN showed superior resistance to light, metal ions, ascorbic acid, and simulated intestinal digestion. After INFOGEST digestion, anthocyanin retention in the intestinal phase was 47% and 51% for the GA- and CGN-coated systems, respectively, and antioxidant activity was better preserved than in the free anthocyanin group. In an oleic-acid-induced HepG2 lipid accumulation model, the CGN carrier showed good biocompatibility and significantly enhanced the lipid-lowering effect of anthocyanins, with the most pronounced reduction in intracellular triglycerides. These results indicate that the CGN carrier has considerable potential for maintaining anthocyanin stability, modulating digestive behavior, and enhancing biological efficacy, and provide a reference for the design of plant-based delivery systems for bioactive ingredients.
No takes yet. Share an insight, caveat, or question.
Zhu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: